Palvella Therapeutics, Inc. ( PVLA ) Q3 2026 Earnings Call November 5, 2026 8:30 AM EST
Company Participants
Bohan Wei - Vice President of Corporate Development & New Product Planning
Wesley Kaupinen - Founder, President, CEO & Director
Ashley Kline
Jeffrey Martini - Chief Scientific Officer
Matthew Korenberg - CFO, Corporate Secretary & Treasurer
Conference Call Participants
Joshua Schimmer - Cantor Fitzgerald & Co., Research Division
Ritu Baral - TD Cowen, Research Division
Graig Suvannavejh - Mizuho Securities USA LLC, Research Division
Annabel Samimy - Stifel, Nicolaus & Company, Incorporated, Research Division
Alethea Young
Presentation
Operator
Good day, and thank you for standing by. Welcome to the Palvella Therapeutics Third Quarter 2026 Financial Results Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.…